Last Update Time:
18-Mar-2025 16:00:00
ISIN:
INE820Y01021
Sector:
Fast Moving Consumer Goods
Symbol:
AJOONI
Ajooni Biotech Limited
₹6.26
₹0.18
(2.96%)
▲
Prev. Close
₹6.08
Open
₹6.05
Close
₹6.30
Range
₹5.95 - ₹6.57
High
₹6.41
Low
₹6.05
Ind. Close
₹0.00
VWAP
₹6.24
The current stock price of Ajooni Biotech Limited is ₹6.26, with a target price range between ₹5.95 and ₹6.57. The stock has experienced a price change of ₹0.18 (2.96%), reflecting recent market volatility.
Today's opening price was ₹6.05, while the previous close stood at ₹6.08.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Ajooni Biotech Limited Price Chart
Ajooni Biotech Limited Pre Open Market Overview: 18-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 6.05
- Previous Close Price: 6.08
- Change: -0.03%
- Total Traded Volume: 30,526
- Total Buy Quantity: 125,539
- Total Sell Quantity: 55,249
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 5.99 | 10.00 | 0.00 |
| 6.00 | 22,270.00 | 0.00 |
| 6.01 | 4,178.00 | 0.00 |
| 6.02 | 24.00 | 0.00 |
| 6.05 | 267.00 | 0.00 |
| 6.08 | 0.00 | 116.00 |
| 6.15 | 0.00 | 81.00 |
| 6.19 | 0.00 | 4,000.00 |
| 6.24 | 0.00 | 5,000.00 |
| 6.50 | 0.00 | 11,700.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 125539
Total Sell Quantity: 55249
Shareholding Patterns of Ajooni Biotech Limited
Key Trade Statistics of Ajooni Biotech Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 5.45 |
| Traded Value (₹ Cr.) | 0.34 |
| Total Market Cap (₹ Cr.) | 107.82 |
| Free Float Market Cap (₹ Cr.) | 78.83 |
| Impact cost | 1.37 |
| Quantity Traded | 544,817.00 |
| Deliverable Quantity | 336,841.00 |
| % of Quantity to Traded | 61.83 |
| Security VaR | 21.56 |
| Index VaR | N/A |
| VaR Margin | 21.56 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 25.06 |
| Face Value | 2 |
Key Price Statistics of Ajooni Biotech Limited
The 52-week high for Ajooni Biotech Limited was ₹10.34, recorded on 04-Sep-2024. On the other hand, the 52-week low stands at ₹4.30, with the lowest value recorded on 20-Mar-2024.
The upper band for trading is ₹6.68, and the lower band is ₹5.47. The price band is 10%.
The stock's daily volatility stands at 3.25, while the annualized volatility is 62.09. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (04-Sep-2024) | 10.34 |
| 52 Week Low (20-Mar-2024) | 4.30 |
| Upper Band | 6.68 |
| Lower Band | 5.47 |
| Price Band (%) | 10 |
| Daily Volatility | 3.25 |
| Annualised Volatility | 62.09 |
| Tick Size | 0.01 |
Key Securities Statistics of Ajooni Biotech Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 07-May-2021 |
| Adjusted P/E | 38.38 |
| Symbol P/E | 38.38 |
| Index | NA |
| Macro-Economic Sector | Fast Moving Consumer Goods |
| Sector | Fast Moving Consumer Goods |
| Industry | Food Products |
| Basic Industry | Animal Feed |
Security Status of Ajooni Biotech Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Ajooni Biotech Limited
| Subject | Date |
|---|---|
| Integrated Filing- Financial | 22-Feb-2025 |
| Updates | 18-Feb-2025 |
| Copy of Newspaper Publication | 14-Feb-2025 |
| Statement of deviation(s) or variation(s) under Reg. 32 | 13-Feb-2025 |
| Outcome of Board Meeting | 13-Feb-2025 |
| Financial Result Updates | 13-Feb-2025 |
| Updates | 06-Feb-2025 |
| Issue of Securities | 05-Feb-2025 |
Corporate Actions of Ajooni Biotech Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 2 | Annual General Meeting | 10-Sep-2024 |
| 2 | Rights 1:1 @ Premium Rs 3/- | 07-May-2024 |
| 2 | Annual General Meeting | 29-Aug-2023 |
| 2 | Rights 29:30 @ Premium Rs 4/- | 25-Nov-2022 |
| 2 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share | 07-Oct-2022 |
| 2 | Annual General Meeting | 13-Sep-2022 |
| 2 | Annual General Meeting | 17-Sep-2021 |
Board Meetings of Ajooni Biotech Limited
Financial Results of Ajooni Biotech Limited
Company Directory of Ajooni Biotech Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.ajoonibiotech.com | Registered Office | D-118, Industrial Area Phase-7, Mohali | MOHALI |
| www.ajoonibiotech.com | Registered Office | D-118, Industrial Area Phase-7, Mohali | MOHALI |
| www.ajoonibiotech.com | Transfer Agent | CAMEO CORPORATE SERVICES LTD. Submaramanian Building, 1 Club House Road, | CHENNAI |
| www.ajoonibiotech.com | Transfer Agent | CAMEO CORPORATE SERVICES LTD. Submaramanian Building, 1 Club House Road, | CHENNAI |
Insider Trading of Ajooni Biotech Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | ISHNEET KAUR | 900000 | Sell |
| 7(2) | JASJOT SINGH | 1808000 | Sell |
| 7(2) | UPNEET KAUR | 1350000 | Sell |
| 7(2) | ISHNEET KAUR | 1400700 | Sell |
| 7(2) | JASJOT SINGH | 1045800 | Sell |
| 7(2) | JASJOT SINGH | 1874653 | Sell |
| 7(2) | JASJOT SINGH | 648769 | Sell |
| 7(2) | UPNEET KAUR | 481000 | Sell |
| 7(2) | JASJOT SINGH | 1632095 | Sell |
| 7(2) | JASJOT SINGH | 2060000 | Sell |
| 7(2) | JASJOT SINGH | 1872000 | Sell |
| 7(2) | UPNEET KAUR | 957959 | Sell |
| 7(2) | JASJOT SINGH | 745338 | Sell |
| 7(2) | HEALTHY BIOSCIENCES PRIVATE LIMITED | 338729 | Sell |
| 7(2) | JASJOT SINGH | 1860000 | Sell |
| 7(2) | UPNEET KAUR | 250658 | Sell |
| 7(2) | JASJOT SINGH | 899498 | Sell |
| 7(2) | UPNEET KAUR | 24250 | Sell |
| 7(2) | UPNEET KAUR | 240000 | Sell |
| 7(2) | JASJOT SINGH | 211142 | Sell |
Annual Reports of Ajooni Biotech Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| Ajooni Biotech Limited | 2023 | 2024 | |
| Ajooni Biotech Limited | 2022 | 2023 | |
| Ajooni Biotech Limited | 2021 | 2022 | |
| Ajooni Biotech Limited | 2020 | 2021 |
Investor Complaints of Ajooni Biotech Limited
Event Calendar of Ajooni Biotech Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Other business matters | To consider and discuss the following items: 1. To consider and final the date of Annual General Meeting to be held. 2. to fix Book Closures dated for the purpose of Annual General Meeting. 3. To consider and approve the notice and Director's Report for the purpose of Annual General Meeting. 4. Any other matter with the permission of the Chair. |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Other business matters | To consider other business matters |
| Other business matters | To consider other business matters |
| Other business matters | To consider other business matters |
| Other business matters | To consider other business matters |
| Other business matters | To consider other business matters |
| Other business matters | 1.ￂﾠￂﾠ To consider and approve the appointment of Company Secretary and Compliance Officer of the Company.2.ￂﾠￂﾠ To consider and approve the appointment of Internal Auditor for financial year 2019-20.3.ￂﾠￂﾠ To take record of the declaration given by the Directors of the Company.4.ￂﾠￂﾠ Any other matter with the permission of the Chair |
| Other business matters | To consider other business matters |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Other business matters | To consider other business matters |
| Fund Raising/Other business matters | AJOONI : 31-Aug-2019 : The Company has informed the Exchange that a Board meeting to be held on August 29, 2019 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 31, 2019, To consider Fund Raising and other business matters |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Fund Raising | To consider Fund Raising |
| Other business matters | Appointment of Company Secretary and Compliance Officer of the Company. |
| Other business matters | 1. To accept the Resignation of Mr. Gurjant Singh as a Director of the company. 2. To sell, transfer or dispose off equity shares held by M/s. Healthy Biosciences Private Limited amongst the promoter group. 3. Any other matter with the permission of the Chair. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Other business matters | To consider other business matters: 1. To fix the Date, Time and Venue for convening 10th Annual General Meeting of the Members of the Company and approve the Draft Notice for the same. 2. To consider and approve the Draft Director s Report for the F.Y. 2019-20 for the purpose of 10th Annual General Meeting. 3. To approve the Book-closure dates as per regulation 42 of the SEBI (LODR) Regulations, 2015 for the purpose of 10th Annual General Meeting of the Company. 4. To appoint the Scrutinizer for Annual General Meeting. 5. Any other business with the permission of chair. |
| Other business matters | To consider other business matters i.e. Intimation of Addition of Agenda of Board Meeting to be held on Tuesday, 10th November, 2020 |
| Bonus/Fund Raising/Other business matters | AJOONI : 23-Jan-2021 : The Company has informed the Exchange that a Board meeting to be held on January 15, 2021 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on January 23, 2021, To consider bonus, Fund Raising and other business matters |
| Bonus/Fund Raising/Other business matters | To consider bonus, Fund Raising and other business matters |
| Other business matters | To consider other business matters |
| Bonus/Other business matters | To consider bonus and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2021 and other business matters |
| Financial Results/Fund Raising/Other business matters | To consider and approve the un audited financial results for the period ended Jun 30, 2021, Fund Raising and other business matters |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Other business matters | Ajooni Biotech Limited has informed the Exchange about Board Meeting to be held on 05-Aug-2022 to consider un-audited Financial Results for the quarter ended June 30, 2022. |
| Financial results | Ajooni Biotech Limited has informed the Exchange about Board Meeting to be held on 05-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Ajooni Biotech Limited has informed the Exchange about Board Meeting to be held on 05-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Ajooni Biotech Limited has informed the Exchange about Board Meeting to be held on 05-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Ajooni Biotech Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2022 to consider un-audited financial statements for the period ended 30th September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results/Other business matters | To consider and approve the un-audited financial results for the period ended December 31, 2023 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| Financial Results | To consider and approve the un-audited financial results for the period ended Jun 30, 2024 |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Fund Raising | To consider Fund Raising |
| Fund Raising/Other business matters | AJOONI : 03-Jan-2025 : The Company has informed the Exchange that a Board meeting to be held on December 31, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on January 03, 2025, To consider Fund Raising and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Ajooni Biotech Limited
Voting Results of Ajooni Biotech Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 03-FEB-2025 | EGM | Alteration in Clause 7 of the Articles Of Association |
| 03-FEB-2025 | EGM | Regularization of Appointment of Mr. Ishtneet Bhatia (Din: 10440990) as an Independent Director of the Company |
| 03-FEB-2025 | EGM | Issuance of Convertible Warrants to Promoters And Non-Promoter Categories of Persons, On a Preferential Basis |
| 03-FEB-2025 | EGM | Increase in Authorized Share Capital |
| 17-SEP-2024 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended 31st March, 2024, together with the Reports of the Board of Directors and Auditors thereon |
| 17-SEP-2024 | AGM | Approval for related party transactions |
| 17-SEP-2024 | AGM | Appointment of M/s. Narinder Kumar and Company (Firm Registration No. 0030737N), Chartered Accountants, as statutory auditors of the company. |
| 17-SEP-2024 | AGM | To re-appoint a Director in place of Mr. Jasjot Singh (DIN: 01937631) who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment. |
| 05-SEP-2023 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended 31st March, 2023, together with the Reports of the Board of Directors and Auditors thereon. |
| 05-SEP-2023 | AGM | To increase the authorized share capital of the company and amend the capital clause in the memorandum of association of the company |
| 05-SEP-2023 | AGM | Approval for Related Party Transactions |
| 05-SEP-2023 | AGM | To re-appoint a Director in place of Mr. Gursimran Singh (DIN: 02209675) who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment. |
| 20-SEP-2022 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended 31st March, 2022, together with the Reports of the Board of Directors and Auditors thereon. |
| 20-SEP-2022 | AGM | Amendment of Capital Clause of the Memorandum of Association of the Company. |
| 20-SEP-2022 | AGM | Sub-division of equity shares of nominal value of Rs. 10/- (Rupees Ten) each fully paid up of the company into five equity shares of nominal value of Rs. 2/- (Rupees Two) each fully paid up. |
| 20-SEP-2022 | AGM | Approval for Related Party Transactions |
| 20-SEP-2022 | AGM | To approve revision in remuneration payable to Mr. Partek Singh (DIN: 07864006), Director of the company. |
| 20-SEP-2022 | AGM | To approve increase in remuneration of Mr. Jasjot Singh, Managing Director of the company |
| 20-SEP-2022 | AGM | To appoint Mr. Gursimran Singh (DIN: 02209675) as a Whole Time Director of the company and fix his remuneration. |
| 20-SEP-2022 | AGM | To re-appoint a Director in place of Mr. Partek Singh (DIN: 07864006) Director, who retires by rotation and being eligible, offers himself for re-appointment. |
FAQs on Ajooni Biotech Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.